NO823707L - Fremgangsmaate for fremstilling av terapeutisk aktive morfinanderivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive morfinanderivater.

Info

Publication number
NO823707L
NO823707L NO823707A NO823707A NO823707L NO 823707 L NO823707 L NO 823707L NO 823707 A NO823707 A NO 823707A NO 823707 A NO823707 A NO 823707A NO 823707 L NO823707 L NO 823707L
Authority
NO
Norway
Prior art keywords
lower alkyl
alkyl
aryl
compound
heteroaryl
Prior art date
Application number
NO823707A
Other languages
English (en)
Norwegian (no)
Inventor
Ernest Mohacsi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO823707L publication Critical patent/NO823707L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
NO823707A 1981-11-09 1982-11-08 Fremgangsmaate for fremstilling av terapeutisk aktive morfinanderivater. NO823707L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/319,482 US4374139A (en) 1981-11-09 1981-11-09 Levorotatory N-substituted acylmorphinans useful as analgesic agents

Publications (1)

Publication Number Publication Date
NO823707L true NO823707L (no) 1983-05-10

Family

ID=23242421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO823707A NO823707L (no) 1981-11-09 1982-11-08 Fremgangsmaate for fremstilling av terapeutisk aktive morfinanderivater.

Country Status (18)

Country Link
US (1) US4374139A (cs)
EP (1) EP0079556A3 (cs)
JP (1) JPS5888364A (cs)
KR (1) KR840002357A (cs)
AU (1) AU9027682A (cs)
CA (1) CA1195324A (cs)
DK (1) DK491582A (cs)
ES (2) ES8500948A1 (cs)
FI (1) FI823824L (cs)
GR (1) GR78317B (cs)
HU (1) HU187425B (cs)
IL (1) IL67180A0 (cs)
MC (1) MC1490A1 (cs)
NO (1) NO823707L (cs)
NZ (1) NZ202404A (cs)
PH (1) PH18458A (cs)
PT (1) PT75815B (cs)
ZA (1) ZA827905B (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4423221A (en) * 1982-06-10 1983-12-27 Sisa Pharmaceutical Laboratories, Inc. 7-Carboethoxy-morphinan-6-one compounds
US4454141A (en) * 1982-09-23 1984-06-12 Sisa Pharmaceutical Laboratories, Inc. Trans-B/C-7-(1-hydroxypentyl)-3-methoxy-17 methyl-6,7-didehydromorphinans, and methods of relieving pain with them
EP0184041A1 (en) * 1984-11-13 1986-06-11 Miles Inc. 6-Methylene morphinan purification technique
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
DE4304450A1 (de) * 1993-02-13 1994-08-18 Boehringer Mannheim Gmbh System zur Zubereitung von Flüssigkeiten
ES2572332T3 (es) 2000-10-31 2016-05-31 Rensselaer Polytech Inst 2,6-metano-3-benzazocinas sustituidas en posición 8 y morfinanos sustituidos en posición 3 como ligandos de receptores opioides
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
CN102316902B (zh) 2009-02-20 2014-09-24 to-BBB控股股份有限公司 基于谷胱甘肽的药物递送系统
IL295075A (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
EP3569234A1 (en) 2009-12-04 2019-11-20 Alkermes Pharma Ireland Limited Morphinan derivatives for the treatment of drug overdose
CA2793725C (en) 2010-03-22 2018-05-01 Rensselaer Polytechnic Institute Carboxamide bioisosteres of opiates
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
PT2725908T (pt) 2011-06-29 2017-08-31 Alkermes Inc Compostos opioides de ação periférica
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
WO2014190271A2 (en) 2013-05-24 2014-11-27 Alkermes Pharma Ireland Limted Methods for treating depressive symptoms
CA2911231C (en) 2013-05-24 2021-12-07 Alkermes Pharma Ireland Limited Morphan and morphinan analogues, and methods of use
US10745402B2 (en) 2017-01-02 2020-08-18 Purdue Pharma L.P. Morphinan derivatives and use thereof
EP4243768A1 (en) 2020-11-12 2023-09-20 Alkermes Pharma Ireland Limited Immediate release multilayer tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723437A (en) * 1970-09-15 1973-03-27 American Home Prod 4,10-(methaniminomethano phenanthrene derivatives
ZA73988B (en) * 1972-03-10 1973-10-31 Hoffmann La Roche Morphinan derivatives
US3914233A (en) * 1972-10-20 1975-10-21 Hoffmann La Roche 4-Hydroxy-N-substituted morphinan derivatives

Also Published As

Publication number Publication date
IL67180A0 (en) 1983-03-31
FI823824A0 (fi) 1982-11-08
ES529349A0 (es) 1985-08-01
NZ202404A (en) 1985-11-08
PT75815B (en) 1986-01-21
ZA827905B (en) 1983-08-31
ES517222A0 (es) 1984-12-01
MC1490A1 (fr) 1983-09-12
DK491582A (da) 1983-05-10
CA1195324A (en) 1985-10-15
FI823824A7 (fi) 1983-05-10
AU9027682A (en) 1983-05-19
EP0079556A2 (de) 1983-05-25
KR840002357A (ko) 1984-06-25
US4374139A (en) 1983-02-15
ES8506635A1 (es) 1985-08-01
PT75815A (en) 1982-12-01
ES8500948A1 (es) 1984-12-01
FI823824L (fi) 1983-05-10
HU187425B (en) 1986-01-28
GR78317B (cs) 1984-09-26
JPS5888364A (ja) 1983-05-26
EP0079556A3 (de) 1983-08-24
PH18458A (en) 1985-07-18

Similar Documents

Publication Publication Date Title
NO823707L (no) Fremgangsmaate for fremstilling av terapeutisk aktive morfinanderivater.
KR100297057B1 (ko) 이미다조피리딘및이를위장질환의치료에사용하는방법
KR910007882B1 (ko) 1-벤질-아미노알킬-피롤리디논의 제조방법
KR101132208B1 (ko) 트리사이클릭 δ-오피오이드 조절자
IE46909B1 (en) Pyridobenzodiazepines
NO161619B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte 5,11-dihydro-6-dibenz(b,e)-azepin-6-on-derivater.
EP0028717A1 (en) 6,7-Benzomorphan derivatives, processes for their production, pharmaceutical compositions containing said derivatives and their use as pharmaceuticals
DE2254298A1 (de) Neue (heteroarylmethyl)-normorphine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
GB1569251A (en) Pyridobenzodiazepines
AU688186B2 (en) (Thiophen-2-YL)-piperidin or tetrahydropyridin carboxamides
AU2002224086B8 (en) Indole derivatives and use thereof in medicines
KR900004148B1 (ko) 피롤로[1,2-a][4,1]벤즈옥사제핀 유도체
HU220874B1 (en) Imidazopyridine-azolidinones, process for producing them, the use thereof and pharmaceutical compositions containing them
EP0491549B1 (en) Novel 15-nitro-2beta, 3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same
EP0035819A1 (en) Quinoline derivatives, pharmaceutical compositions containing such compounds, and methods for the preparation of these compounds
JPH10505332A (ja) アシルイミダゾピリジン
US4764517A (en) 8α-(N,N-diethylsulfamoylamino)-6-n-propyl ergoline useful as a prolactin secretion inhibitor, anti-parkinson, anti-depressant agent
US3047571A (en) Derivatives of oxopiperidinyl phenthiazines
JP2003513006A (ja) 三環性鎮痛薬
CA2787063A1 (en) Nicotinic acetylcholine receptor modulators
EP0333073A2 (en) N-cycloalkylaminoethylbenzamide derivatives, their synthesis and pharmaceutical preparations
FI68225B (fi) Foerfarande foer framstaellning av 6,7-benzomorfanderivat vilka aer anvaendbara som analgetiska medel antagonister foer nakotiska medel och inhibitorer foer sekretion av luteinise rigshormon
KR910004449B1 (ko) 인돌 화합물, 이들의 제조방법 및 이들 화합물을 함유하는 약학적 조성물
HU177640B (en) Process for preparing new laevorotatory derivatives of 3-phenoxy-morphinene
WO1996036604A1 (en) 4-ARYLCYCLOHEPTA[c]PYRROLE ANALGESICS